Colleen Koch, MD, MS, MBA
After receiving her MD in 1987 from the University of Cincinnati College of Medicine, Dr. Colleen Koch completed her internship in internal medicine at Cleveland Clinic the following year. She completed her residency in anesthesiology and also served as a senior resident with a sub-specialization in cardiac, thoracic and vascular anesthesiology at Brigham and Women's Hospital in Boston. In 2001, she received a master's degree in clinical research, design and statistical analysis from the University of Michigan School of Public Health and in 2010 an MBA at Case Western Reserve University.
A well-respected anesthesiologist, Dr. Koch comes to Hopkins from Cleveland Clinic, which she joined in 1992. Most recently, she was the vice chair of education and research for its Department of Cardiothoracic Anesthesia. She also served as a professor of anesthesiology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She held joint appointments with Cleveland Clinic's Quality & Patient Safety Institute and departments of Medical Operations and of Thoracic and Cardiovascular Surgery.
In addition to her notable program management expertise, Dr. Koch has been actively involved in interdisciplinary research and was a member of Cleveland Clinic's Heart & Vascular Institute, where she mentored cardiothoracic surgical fellows in clinical research.
Dr. Koch serves on the leadership and editorial boards of many esteemed societies and journals, including the Society of Cardiovascular Anesthesiologists, Journal of Cardiothoracic and Vascular Anesthesia, The Annals of Thoracic Surgery and the International Anesthesia Research Society.
About The Mark C. Rogers Professorship
Dr. Rogers left Johns Hopkins in 1992 to serve as vice chancellor for health affairs at Duke University Medical Center and as executive director and chief executive officer at Duke Hospital and Health Network. He next became a senior executive of the firm that sequenced the human genome, head of a major biotech investment bank, and a founder of multiple public biopharmaceutical companies. Dr. Rogers is a member of the Institute of Medicine of the National Academy of Sciences.